CH-799

N/A

Report date: 2023/05/22 10:17:31

Base Information

Drug NameCH-799
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionPurine nucleoside phosphorylase inhibitors
TargetsPurine nucleoside phosphorylase
Therapy Area/IndicationsRejection of organ transplantationAutoimmune DiseasesIrritable Bowel Syndrome +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCelltech Group Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCelltech Group Ltd
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationAutoimmune DiseasesIrritable Bowel Syndrome +[5] 

Other Information

ATC CodeN/A
Related LinksN/A